Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma
Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in Black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in Black patients. Our panel of expert Hematology/Oncology faculty convene a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among Black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center. The goals of our educational program are to address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM.
  • Hematology/Oncology
  • Self-study / Enduring
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
The Criminalization of Trauma and the School to Prison Pipeline
This 2-hour meeting will explain the historical background of policing and the parallels between current policing tactics and the school to prison pipeline. We will explore trauma informed approaches to care and strategies to prevent compassion fatigue. 
  • Nursing
  • Pediatrics
  • Psychiatry and Mental Health
  • Webinar live
  • 2.00 ANCC
  • 2.00 Participation
Event date June 15, 2023
16th Annual Inflammatory Bowel Disease: The Art and Science in the Diagnosis and Treatment 2023
Join us in-person  for IBD Boston 2023. September 8-9, 2023
  • Gastroenterology
  • Conference / meeting
  • 10.25 ABIM MOC II
  • 10.25 ABP MOC
  • 11.25 ACPE Pharmacy
  • 11.25 AMA PRA Category 1 Credit™
  • 11.50 ANCC
  • 11.25 Participation
Event date September 8, 2023